packageC1InhibitorPlasmaDerived

c1-inhibitor, plasma derived

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Plasma-derived C1 inhibitor is used to treat hereditary angioedema. It is an approved medicine, with an authorised product in the European Union.

Summary written by glm-5.3-flash from Wikidata Q22075742 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:c1-inhibitor, plasma derived
ATC codes:B06AC01
DrugBank:DB06404
Wikidata:Q22075742
molar mass:68000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown